These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 24819170)
1. NUCKS1 overexpression is a novel biomarker for recurrence-free survival in cervical squamous cell carcinoma. Gu L; Xia B; Zhong L; Ma Y; Liu L; Yang L; Lou G Tumour Biol; 2014 Aug; 35(8):7831-6. PubMed ID: 24819170 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of LAPTM4B-35 in cervical carcinoma: a clinicopathologic study. Meng F; Luo C; Hu Y; Yin M; Lin M; Lou G; Zhou R Int J Gynecol Pathol; 2010 Nov; 29(6):587-93. PubMed ID: 20881850 [TBL] [Abstract][Full Text] [Related]
3. Elevated CTHRC1 expression is an indicator for poor prognosis and lymph node metastasis in cervical squamous cell carcinoma. Li N; Chen L; Liu C; Jiang Y; Rong J Hum Pathol; 2019 Mar; 85():235-241. PubMed ID: 30381261 [TBL] [Abstract][Full Text] [Related]
4. Special AT-rich sequence-binding protein 1: a novel biomarker predicting cervical squamous cell carcinoma prognosis and lymph node metastasis. Wang S; Wang L; Zhang Y; Liu Y; Meng F; Ma J; Shang P; Gao Y; Huang Q; Chen X Jpn J Clin Oncol; 2015 Sep; 45(9):812-8. PubMed ID: 26117495 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Expression and Prognostic Significance of CD97 and its Ligand DAF in Human Cervical Squamous Cell Carcinoma. He Y; Wang W; Xu L; Li L; Liu J; Feng M; Bu H Int J Gynecol Pathol; 2015 Sep; 34(5):473-9. PubMed ID: 26107567 [TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid binding protein 1 overexpression is an indicator for disease-free survival in cervical cancer. Zhang M; Li N; Liang Y; Liu J; Zhou Y; Liu C Int J Clin Oncol; 2017 Apr; 22(2):347-352. PubMed ID: 28039537 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer. Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253 [TBL] [Abstract][Full Text] [Related]
8. Nuclear localizaiton of β-catenin is associated with poor survival and chemo-/radioresistance in human cervical squamous cell cancer. Zhang Y; Liu B; Zhao Q; Hou T; Huang X Int J Clin Exp Pathol; 2014; 7(7):3908-17. PubMed ID: 25120767 [TBL] [Abstract][Full Text] [Related]
9. NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer. Niu C; Sun X; Zhang W; Li H; Xu L; Li J; Xu B; Zhang Y Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775588 [TBL] [Abstract][Full Text] [Related]
10. Phosphorylated c-Src is a novel predictor for recurrence in cervical squamous cell cancer patients. Hou T; Xiao J; Zhang H; Gu H; Feng Y; Li J Int J Clin Exp Pathol; 2013; 6(6):1121-7. PubMed ID: 23696930 [TBL] [Abstract][Full Text] [Related]
11. Lgr5 is a potential prognostic marker in patients with cervical carcinoma. Sun B; Ye X; Li Y; Zhang W Int J Clin Exp Pathol; 2015; 8(2):1783-9. PubMed ID: 25973068 [TBL] [Abstract][Full Text] [Related]
12. Increase of Mcm3 and Mcm4 expression in cervical squamous cell carcinomas. Gan N; Du Y; Zhang W; Zhou J Eur J Gynaecol Oncol; 2010; 31(3):291-4. PubMed ID: 21077471 [TBL] [Abstract][Full Text] [Related]
13. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy. Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of TRAIL signalling molecules in cervical squamous cell carcinoma. Yao Q; Du J; Lin J; Luo Y; Wang Y; Liu Y; Zhang B; Ren C; Liu C J Clin Pathol; 2016 Feb; 69(2):122-7. PubMed ID: 26254281 [TBL] [Abstract][Full Text] [Related]
15. Correlation between reticulum ribosome-binding protein 1 (RRBP1) overexpression and prognosis in cervical squamous cell carcinoma. Zhu J; Zhao R; Xu W; Ma J; Ning X; Ma R; Meng F Biosci Trends; 2020 Sep; 14(4):279-284. PubMed ID: 32536673 [TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer. Hazelbag S; Kenter GG; Gorter A; Fleuren GJ Int J Cancer; 2004 Dec; 112(6):1020-8. PubMed ID: 15386352 [TBL] [Abstract][Full Text] [Related]
17. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma. Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716 [TBL] [Abstract][Full Text] [Related]
18. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study]. Wang W; Shang C; Huang J; Chen S; Shen H; Yao S Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872 [TBL] [Abstract][Full Text] [Related]
19. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma. Duk JM; Groenier KH; de Bruijn HW; Hollema H; ten Hoor KA; van der Zee AG; Aalders JG J Clin Oncol; 1996 Jan; 14(1):111-8. PubMed ID: 8558185 [TBL] [Abstract][Full Text] [Related]
20. Aurora-A affects radiosenstivity in cervical squamous cell carcinoma and predicts poor prognosis. Ma Y; Yang J; Wang R; Zhang Z; Qi X; Liu C; Ma M Oncotarget; 2017 May; 8(19):31509-31520. PubMed ID: 28404933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]